Yes, do explain how you can be happy with:
-450k base wage plus 150k bonus for a CEO of a speculative stock years from profitability. + options/performance shares.
-Slow progress.
-Ambiguous and dishonest information release. Just 1 example is an interview where "plasma levels are adequate", whilst the company doubles back to a phase 1 trial to desperately increase infusion rates to boost plasma concentrations, all while not releasing results to share holders.
Ann: Murdoch Children's R327 Efficacy UTI in-vivo, page-20
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
60.0¢ |
Change
0.030(5.26%) |
Mkt cap ! $122.3M | |||
| Open | High | Low | Value | Volume |
| 56.5¢ | 62.0¢ | 56.5¢ | $158.1K | 263.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 77741 | 60.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 61.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| RCE (ASX) Chart |